
    
      Primary Objective: Evaluation the pharmacokinetics, safety and tolerability of single
      intravenous of ABCD in Chinese healthy subjects.

      Secondary Objective: Evaluation the safety and tolerability of single intravenous of ABCD in
      Chinese healthy subjects.

      Exploratory Objective:Evaluation the effect of single intravenous ABCD on early renal injury
      indicators (KIM-1 and cystatin C) in Chinese healthy subjects.
    
  